Telmify-MT Tablet ER
Marketer
Pazia Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telmify-MT Tablet ER
Telmify-MT Extended-Release tablets manage hypertension, reducing the risk of cardiovascular events like strokes and heart attacks. Early use enhances survival rates post-heart attack. Consistent blood levels are achieved by taking the medication with food at the same time daily, as directed by your physician. Continued use is crucial, even if you feel well, as hypertension is often asymptomatic; premature cessation can worsen your condition. Lifestyle modifications – regular exercise, weight management, and a healthy diet – further support blood pressure control. Strictly adhere to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, and electrolyte levels may be necessary. Inform your doctor of any liver or kidney issues before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Disclose all other medications, particularly those for hypertension or cardiac conditions.
Uses of Telmify-MT Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telmify-MT Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Telmify-MT Tablet ER with a meal.
Common Side effects of Telmify-MT Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telmify-MT Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmify-MT Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Telmify-MT Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telmify-MT Tablet ER, offer a dual approach to blood pressure management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmify-MT Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telmify-MT tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telmify-MT tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Telmify-MT tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Telmify-MT Extended-Release tablets without requiring any dosage modification.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Telmify-MT Extended-Release tablets. Dosage modification of Telmify-MT Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Telmify-MT Tablet ER :
Should you forget a Telmify-MT Extended-Release Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Telmify-MT Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | HEART |



